-
-
Overview
-
Carfilzomib is an anti-cancer tetrapeptide epoxyketone drug and is used for the treatment of multiple myeloma.
Please contact us at for specific academic pricing.
Background
Carfilzomib prevents tumor growth by inhibiting 20S proteasome activity which leads to an accumulation of polyubiquinated proteins, and ultimately, cell cycle arrest or apoptosis.
-
- Properties
-
Overview